# clm_CE05B7C86D54

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: board_member  
value: David P. Schenkein  
valid_from: 2023-09-08  
valid_to: null  
published: 2023-09-08  
recorded: 2026-11-12  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-12  
cite: AsOf. "Regeneron Pharmaceuticals board member: David P. Schenkein", as of 2023-09-08. Claim clm_CE05B7C86D54, https://asof.is/claim/clm_CE05B7C86D54, accessed 2026-11-13. Source: https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/0001104659-23-099345-index.htm.  
checked: 2026-11-12 · its source page states the value and the date, as read by an AI model  

> On September 8, 2023, Regeneron’s board of directors (the “ Board ”) elected Kathryn Guarini, Ph.D. as a Class III director and David P. Schenkein, M.D. as a Class II director to fill the two vacancies on the Board.

What https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/0001104659-23-099345-index.htm says, word for word.

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000110465923099345/0001104659-23-099345-index.htm (primary, SEC EDGAR 8-K Item 5.02, published 2023-09-08)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.